Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001507650-25-000003

Co-Chief Executive Officer bought 26,680 shares at $18.74 ($499,983)

  • Co-Chief Executive Officer acquired 14,247,597 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Mahkam · Co-Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-21 Grant or award : show line 1 in the form +266,808 $18.74 $4,999,982 25,724,474 I
2025-10-21 Purchase : show line 2 in the form +26,680 $18.74 $499,983 76,680 I
2025-10-21 Grant or award : show line 3 in the form +13,980,789 $18.74 $261,999,986 570,073,879 I
Open-market purchases · 26,680 sh · avg $18.74 · $499,983
Loading xslF345X05/wk-form4_1761249988.xml…